349 related articles for article (PubMed ID: 34792614)
21. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
[TBL] [Abstract][Full Text] [Related]
22. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
Mitchell KG; Ikoma N; Nelson DB; Maru DM; Erasmus JJ; Weston BR; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Swisher SG; Sepesi B; Walsh GL; Correa AM; Das P; Blum MA; Badgwell BD; Hofstetter WL
Ann Thorac Surg; 2019 Sep; 108(3):845-851. PubMed ID: 31102632
[TBL] [Abstract][Full Text] [Related]
23. Proximal Gastrectomy Versus Total Gastrectomy for Siewert II/III Adenocarcinoma of the Gastroesophageal Junction: a Systematic Review and Meta-analysis.
Li X; Gong S; Lu T; Tian H; Miao C; Liu L; Jiang Z; Hao J; Jing K; Yang K; Guo T
J Gastrointest Surg; 2022 Jun; 26(6):1321-1335. PubMed ID: 35355172
[TBL] [Abstract][Full Text] [Related]
24. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of the effect of lymph node dissection performed by Ivor-Lewis or left-sided thoracic esophagogastrectomy for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
Duan XF; Gong L; Ma MQ; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):190-194. PubMed ID: 28316217
[No Abstract] [Full Text] [Related]
26. Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction.
Xiao JW; Liu ZL; Ye PC; Luo YJ; Fu ZM; Zou Q; Wei SJ
World J Gastroenterol; 2015 Sep; 21(34):9999-10007. PubMed ID: 26379405
[TBL] [Abstract][Full Text] [Related]
27. Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction.
Goto H; Tokunaga M; Sugisawa N; Tanizawa Y; Bando E; Kawamura T; Niihara M; Tsubosa Y; Terashima M
Gastric Cancer; 2013 Oct; 16(4):590-5. PubMed ID: 23179369
[TBL] [Abstract][Full Text] [Related]
28. [Surgical strategy for adenocarcinoma of esophagogastric junction].
Lu Y; Zhang K; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532
[TBL] [Abstract][Full Text] [Related]
29. Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: a retrospective study of 136 cases.
Duan X; Shang X; Tang P; Jiang H; Yu Z
ANZ J Surg; 2018 Apr; 88(4):E264-E267. PubMed ID: 28503799
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of laparoscopic gastrectomy for patients with Siewert-type II/III adenocarcinoma of the esophagogastric junction: A propensity score matching analysis.
Shi Y; Li L; Xiao H; Guo S; Wang G; Tao K; Dong J; Zong L
PLoS One; 2018; 13(9):e0203125. PubMed ID: 30256806
[TBL] [Abstract][Full Text] [Related]
31. Laparoscopic en bloc lower mediastinal lymph node dissection via transhiatal approach for adenocarcinoma of esophagogastric junction.
Sakaguchi M; Hosogi H; Kanaya S
Surg Oncol; 2021 Mar; 36():34-35. PubMed ID: 33285434
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of lymph node (No.5 and No.6) metastasis and significance of lymph node dissection in Siewert type II esophagogastric junction adenocarcinoma (AEG): No.5 and No.6 lymph node metastases of AEG and clearance.
Zhang X; He XD; Zhang YC; Yang KH; Tian JH; Chen YL
Medicine (Baltimore); 2021 Sep; 100(35):e27106. PubMed ID: 34477150
[TBL] [Abstract][Full Text] [Related]
33. Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction.
Hasegawa S; Yoshikawa T; Rino Y; Oshima T; Aoyama T; Hayashi T; Sato T; Yukawa N; Kameda Y; Sasaki T; Ono H; Tsuchida K; Cho H; Kunisaki C; Masuda M; Tsuburaya A
Ann Surg Oncol; 2013 Dec; 20(13):4252-9. PubMed ID: 23943020
[TBL] [Abstract][Full Text] [Related]
34. Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study.
Lin X; Li Z; Tan C; Ye X; Xiong J; Liu J; Mo A; Shi Y; Qian F; Yu P; Zhao Y
Front Oncol; 2021; 11():748694. PubMed ID: 34926257
[TBL] [Abstract][Full Text] [Related]
35. Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures.
Duan XF; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
Medicine (Baltimore); 2017 Feb; 96(7):e6120. PubMed ID: 28207537
[TBL] [Abstract][Full Text] [Related]
36. [Choice of surgical approach for Siewert II and III adenocarcinomas of the esophagogastric junction].
Zhang X; Yang J; Ping H; Zuo H; Yang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Sep; 17(9):924-6. PubMed ID: 25273665
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of Siewert type II adenocarcinoma of the esophagogastric junction: the perspectives from thoracic surgery].
Li ZY; Gu YM; Wang WP; Chen LQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):109-113. PubMed ID: 35176820
[TBL] [Abstract][Full Text] [Related]
38. [Five-step maneuver of transthoracic single-port assisted laparoscopic lower mediastinal lymph node dissection for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
Luo SJ; Xiong WW; Chen Y; Li ZY; Li E; Zeng HP; Zheng YS; Luo LJ; Li J; Cui ZM; Wan J; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Aug; 24(8):684-690. PubMed ID: 34412185
[No Abstract] [Full Text] [Related]
39. Long-term oncologic and surgical outcomes of robotic and laparoscopic gastrectomy for Siewert II/III esophagogastric junction carcinoma: A propensity score-matched retrospective cohort study.
Lin X; Tan C; Li Z; Wu W; Cheng X; Qian F; Shi Y; Zhao Y
Eur J Surg Oncol; 2023 Sep; 49(9):106898. PubMed ID: 37019806
[TBL] [Abstract][Full Text] [Related]
40. Can Clinical Stage in the 8
Watanabe H; Hasegawa S; Kumazu Y; Hashimoto I; Komori K; Suematsu H; Kano K; Fujikawa H; Aoyama T; Yamada T; Yukawa N; Yoshikawa T; Rino Y; Saito A; Ogata T; Oshima T
In Vivo; 2023; 37(4):1790-1796. PubMed ID: 37369497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
